Log In
BCIQ
Print this Print this
 

OvaRex, OvaRex Mab, oregovomab

  Manage Alerts
Collapse Summary General Information
Company Quest PharmaTech Inc.
Description mAb targeting CA 125
Molecular Target CA 125
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$1.3M

$0.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today